Several genetically engineered mouse prostate tumor models (GEMMs) based on targeted bi-allelic deletion of the Pten tumor suppressor gene have been developed, which all resemble to a certain extent the several stages of human prostate cancer [20–27]. The gene discussed is PTEN; the disease is neoplasm.